VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

Overview of attention for article published in Frontiers in Pharmacology, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,960 followers.

@udai_banerji @srwhittaker @ICR_London @royalmarsdenNHS https://t.co/ShvdkSeeBN VS-4718 FAK inhibitor, very similar to the Defactinib, also promising in Multi Drug Resistance #MDR

26 Feb 2020

Reply Repost Favourite

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters https://t.co/Y170Eql3kW

21 Nov 2018

Reply Repost Favourite

SJU faculty publication--"VS-4718 Antagonizes Multidrug Resistance in ABCB1-and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters." By Zhe-Sheng Chen, Dong H Yang, et al. In FRONTIERS IN PHARMACOLOGY, 9: OCT 30 2018.

07 Nov 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.